Benefit of Primary Tumor Resection in Stage IV, Grade 1 and 2, Pancreatic Neuroendocrine Tumors: A Propensity-Score Matched Cohort Study: Erratum

DOI: https://doi.org/10.1097/as9.0000000000000290

2023-06-01

Annals of Surgery Open

Abstract:[This corrects the article DOI: 10.1097/AS9.0000000000000151.].

English Else

What problem does this paper attempt to address?

Pathologic Stage of Nonsmall Cell Lung Cancer Patients Presenting as Resectable Cases After Neoadjuvant Therapy Did Not Predict the Prognosis: Erratum

DOI: https://doi.org/10.1097/01.md.0000499790.86340.f9

IF: 1.6

2015-10-01

Medicine

Abstract:Did Not Predict the Prognosis: Erratum I n the article ‘‘Pathologic Stage of Nonsmall Cell Lung Cancer Patients Presenting as Resectable Cases After Neoadjuvant Therapy Did Not Predict the Prognosis’’, which appeared in Volume 94, Issue 40 of Medicine, the total number of patients enrolled in the study should have been stated as 609, not 605, as was stated in the Materials and Methods section. The article has since been corrected online.

Medicine
Corrigendum: Whole-genome Landscape of Pancreatic Neuroendocrine Tumours.

Aldo Scarpa,David K Chang,Katia Nones,Vincenzo Corbo,Ann-Marie Patch,Peter Bailey,Rita T Lawlor,Amber L Johns,David K Miller,Andrea Mafficini,Borislav Rusev,Maria Scardoni,Davide Antonello,Stefano Barbi,Katarzyna O Sikora,Sara Cingarlini,Caterina Vicentini,Skye McKay,Michael C J Quinn,Timothy J C Bruxner,Angelika N Christ,Ivon Harliwong,Senel Idrisoglu,Suzanne McLean,Craig Nourse,Ehsan Nourbakhsh,Peter J Wilson,Matthew J Anderson,J Lynn Fink,Felicity Newell,Nick Waddell,Oliver Holmes,Stephen H Kazakoff,Conrad Leonard,Scott Wood,Qinying Xu,Shivashankar Hiriyur Nagaraj,Eliana Amato,Irene Dalai,Samantha Bersani,Ivana Cataldo,Angelo P Dei Tos,Paola Capelli,Maria Vittoria Davì,Luca Landoni,Anna Malpaga,Marco Miotto,Vicki L J Whitehall,Barbara A Leggett,Janelle L Harris,Jonathan Harris,Marc D Jones,Jeremy Humphris,Lorraine A Chantrill,Venessa Chin,Adnan M Nagrial,Marina Pajic,Christopher J Scarlett,Andreia Pinho,Ilse Rooman,Christopher Toon,Jianmin Wu,Mark Pinese,Mark Cowley,Andrew Barbour,Amanda Mawson,Emily S Humphrey,Emily K Colvin,Angela Chou,Jessica A Lovell,Nigel B Jamieson,Fraser Duthie,Marie-Claude Gingras,William E Fisher,Rebecca A Dagg,Loretta M S Lau,Michael Lee,Hilda A Pickett,Roger R Reddel,Jaswinder S Samra,James G Kench,Neil D Merrett,Krishna Epari,Nam Q Nguyen,Nikolajs Zeps,Massimo Falconi,Michele Simbolo,Giovanni Butturini,George Van Buren,Stefano Partelli,Matteo Fassan,Kum,Anthony J Gill,David A Wheeler,Richard A Gibbs,Elizabeth A Musgrove,Claudio Bassi,Giampaolo Tortora,Paolo Pederzoli,John V Pearson,Nicola Waddell,Andrew V Biankin,Sean M Grimmond

DOI: https://doi.org/10.1038/nature24026

IF: 64.8

2017-01-01

Nature

Abstract:This corrects the article DOI: 10.1038/nature21063.
Erratum: Medical and Surgical Management of the Failed Pancreas Transplant: Erratum

DOI: https://doi.org/10.1097/TXD.0000000000001614

2024-02-16

Abstract:[This corrects the article DOI: 10.1097/TXD.0000000000001543.].
Correction To: Early Presence of Anti-Angiogenesis-related Adverse Events As a Potential Biomarker of Antitumor Efficacy in Metastatic Gastric Cancer Patients Treated with Apatinib: a Cohort Study

Xinyang Liu,Shukui Qin,Zhichao Wang,Jianming Xu,Jianping Xiong,Yuxian Bai,Zhehai Wang,Yan Yang,Guoping Sun,Liwei Wang,Leizhen Zheng,Nong Xu,Ying Cheng,Weijian Guo,Hao Yu,Tianshu Liu,Pagona Lagiou,Jin Li

DOI: https://doi.org/10.1186/s13045-017-0545-5

IF: 28.5

2017-01-01

Journal of Hematology & Oncology

Abstract:The original article [1] contains two errors in Table 2
Corrigendum to "Long recurrence-free survival of localized rectal melanoma after abdominoperineal resection in comparison to partial excision and highlighting the place of immunotherapy: A case report."

DOI: https://doi.org/10.1177/20542704241260192

2024-06-02

JRSM Open

Abstract:[This corrects the article DOI: 10.1177/20542704221148059.].
Publisher Correction: Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumors

Paloma Cejas,Yotam Drier,Koen M A Dreijerink,Lodewijk A A Brosens,Vikram Deshpande,Charles B Epstein,Elfi B Conemans,Folkert H M Morsink,Mindy K Graham,Gerlof D Valk,Menno R Vriens,Carlos Fernandez-Del Castillo,Cristina R Ferrone,Tomer Adar,Michaela Bowden,Holly J Whitton,Annacarolina Da Silva,Alba Font-Tello,Henry W Long,Elizabeth Gaskell,Noam Shoresh,Christopher M Heaphy,Ewa Sicinska,Matthew H Kulke,Daniel C Chung,Bradley E Bernstein,Ramesh A Shivdasani

DOI: https://doi.org/10.1038/s41591-019-0573-5

Abstract:An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Erratum: Efficacy of Flap-based Posterior Trunk Reconstruction after Vertebrectomy and Radiation Therapy: A Retrospective Cohort Study-Erratum

DOI: https://doi.org/10.1097/GOX.0000000000005425

2023-10-18

Abstract:[This corrects the article DOI: 10.1097/GOX.0000000000005242.].
Erratum: Prognostic Effect of Sarcopenia in Hepatocellular Carcinoma Patients Targeted with Interventional Therapy Combined with Immunotherapy and Targeted Therapy [Corrigendum]

DOI: https://doi.org/10.2147/JHC.S467902

2024-03-14

Abstract:[This corrects the article DOI: 10.2147/JHC.S444530.].
Correction to: Primary gliosarcoma: epidemiology, clinical presentation, management, and survival

Ruichong Ma,Delia-Marina Alexe,Erlick A Pereira

DOI: https://doi.org/10.23736/S0390-5616.20.05218-2

Abstract:This corrects the article DOI: 10.23736/S0390-5616.17.04077-2.
Corrigendum: Association between pathological characteristics and recurrence score by OncotypeDX in resected T1-3 and N0-1 breast cancer: a real-life experience of a North Hungarian regional center

Dániel Deme,Bálint Ferenc Tamaskovics,Nizar Jammoul,Sándor Kovács,Kmmanuel Oladunjoye Kayode,James W Grice,András Telekes

DOI: https://doi.org/10.3389/pore.2024.1611862

2024-07-08

Abstract:[This corrects the article DOI: 10.3389/pore.2024.1611735.].
Erratum to maintaining excellent outcomes: the impact of age cutoff reclassification on reduced therapy for neuroblastoma patients

Editorial Office

DOI: https://doi.org/10.21037/tp-2024-02

2024-09-02

Translational Pediatrics

Abstract:Editorial Office Translational Pediatrics Submitted Jul 15, 2024. Accepted for publication Jul 25, 2024. Published online Aug 28, 2024. doi: 10.21037/tp-2024-02 Erratum to: Transl Pediatr 2023;12:1926-30. The article (1) entitled "Maintaining excellent outcomes: the impact of age cutoff reclassification on reduced therapy for neuroblastoma patients" ( Transl Pediatr 2023;12:1926-30. doi: 10.21037/tp-23-391) unfortunately contained some mistakes in the main text on page 1929. In paragraph 14, the "event-free-survival" should be "overall survival". The OS should be EFS. The data "91%±4.4% (≤2006) versus 88%±4.3% (>2006)" should be "89%±5.1% (≤2006) versus 87%±4.6% (>2006)". The corrected content is presented as below: Survival analyses revealed that there were no significant differences in overall survival after the reassignment being 89%±5.1% (≤2006) versus 94%±3.2% (>2006). The similar trend was observed for EFS showing 89%±5.1% (≤2006) versus 87%±4.6% (>2006). The small increase in OS observed in the group of patients treated >2006 could be due to the better response of a small subset of patients that relapse. The authors apologize for these errors and state that these errors do not change the scientific conclusions of the article in any way. Click here to view the updated version of the article. Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.

pediatrics
Erratum: Preoperative immunological plasma markers TRAIL, CSF1, and TIE2 predict survival after resection for biliary tract cancer

Frontiers Production Office

DOI: https://doi.org/10.3389/fonc.2023.1281693

2023-09-27

Abstract:[This corrects the article DOI: 10.3389/fonc.2023.1169537.].
Erratum: Genetic Predisposition to Numerous Large Ulcerating Basal Cell Carcinomas and Response to Immune Therapy: Erratum

DOI: https://doi.org/10.1097/JD9.0000000000000184

Abstract:[This corrects the article DOI: 10.1097/JD9.0000000000000170.].
Correction: A phase II trial of 1st-line modified-FOLFOXIRI plus bevacizumab treatment for metastatic colorectal cancer harboring RAS mutation: JACCRO CC-11

Hironaga Satake,Yu Sunakawa,Yuji Miyamoto,Masato Nakamura,Hiroshi Nakayama,Manabu Shiozawa,Akitaka Makiyama,Kazuma Kobayashi,Yutaro Kubota,Misuzu Mori,Masahito Kotaka,Akinori Takagane,Masahiro Gotoh,Masahiro Takeuchi,Masashi Fujii,Wataru Ichikawa,Takashi Sekikawa

DOI: https://doi.org/10.18632/oncotarget.25775

2018-07-06

Oncotarget

Abstract:[This corrects the article DOI: 10.18632/oncotarget.24702.].
Erratum to "Additional biomarkers for pathological complete response in triple negative breast cancer"

DOI: https://doi.org/10.1177/17588359241290373

2024-10-21

Abstract:[This corrects the article DOI: 10.1177/17588359241267148.].
Corrigendum: Neoadjuvant Tislelizumab Combined with Chemotherapy in Locally Advanced Oral or Oropharyngeal Squamous Cell Carcinoma: a Real-World Retrospective Study.

Wen-Jie Wu,Qian Liu,Pu-Gen An,Lin Wang,Jian-Yun Zhang,Yan Chen,Tong Zhang,Jie Zhang

DOI: https://doi.org/10.3389/fimmu.2023.1346845

IF: 7.3

2024-01-01

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2023.1282629.].
Erratum: Preoperative Frailty Risk in Cranioplasty Patients: Risk Analysis Index Predicts Adverse Outcomes-Erratum

DOI: https://doi.org/10.1097/GOX.0000000000005288

2023-09-06

Abstract:[This corrects the article DOI: 10.1097/GOX.0000000000005059.].
ERRATUM: Correction of the Conflict of Interest. Difference in prognostic impact of lateral pelvic lymph node metastasis between pre- and post-neoadjuvant chemoradiotherapy in rectal cancer patients

Byeo Lee Lim,In Ja Park,Young Il Kim,Chan Wook Kim,Jong Lyul Lee,Yong Sik Yoon,Seok-Byung Lim

DOI: https://doi.org/10.4174/astr.2024.107.3.186

Abstract:[This corrects the article on p. 205 in vol. 104, PMID: 37051159.].
The autophagy-related genes Beclin1 and LC3 in the prognosis of pancreatic cancer [Retraction]

DOI: https://doi.org/10.62347/LSDX2047

2024-09-15

Abstract:[This retracts the article on p. 2989 in vol. 12, PMID: 31934136.].
Erratum: Mesenchymal Stem Cell-Based NK4 Gene Therapy in Nude Mice Bearing Gastric Cancer Xenografts [Corrigendum]

DOI: https://doi.org/10.2147/DDDT.S493671

2024-10-07

Abstract:[This corrects the article DOI: 10.2147/DDDT.S71466.].

Benefit of Primary Tumor Resection in Stage IV, Grade 1 and 2, Pancreatic Neuroendocrine Tumors: A Propensity-Score Matched Cohort Study: Erratum

Pathologic Stage of Nonsmall Cell Lung Cancer Patients Presenting as Resectable Cases After Neoadjuvant Therapy Did Not Predict the Prognosis: Erratum

Corrigendum: Whole-genome Landscape of Pancreatic Neuroendocrine Tumours.

Erratum: Medical and Surgical Management of the Failed Pancreas Transplant: Erratum

Correction To: Early Presence of Anti-Angiogenesis-related Adverse Events As a Potential Biomarker of Antitumor Efficacy in Metastatic Gastric Cancer Patients Treated with Apatinib: a Cohort Study

Corrigendum to "Long recurrence-free survival of localized rectal melanoma after abdominoperineal resection in comparison to partial excision and highlighting the place of immunotherapy: A case report."

Publisher Correction: Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumors

Erratum: Efficacy of Flap-based Posterior Trunk Reconstruction after Vertebrectomy and Radiation Therapy: A Retrospective Cohort Study-Erratum

Erratum: Prognostic Effect of Sarcopenia in Hepatocellular Carcinoma Patients Targeted with Interventional Therapy Combined with Immunotherapy and Targeted Therapy [Corrigendum]

Correction to: Primary gliosarcoma: epidemiology, clinical presentation, management, and survival

Corrigendum: Association between pathological characteristics and recurrence score by OncotypeDX in resected T1-3 and N0-1 breast cancer: a real-life experience of a North Hungarian regional center

Erratum to maintaining excellent outcomes: the impact of age cutoff reclassification on reduced therapy for neuroblastoma patients

Erratum: Preoperative immunological plasma markers TRAIL, CSF1, and TIE2 predict survival after resection for biliary tract cancer

Erratum: Genetic Predisposition to Numerous Large Ulcerating Basal Cell Carcinomas and Response to Immune Therapy: Erratum

Correction: A phase II trial of 1st-line modified-FOLFOXIRI plus bevacizumab treatment for metastatic colorectal cancer harboring RAS mutation: JACCRO CC-11

Erratum to "Additional biomarkers for pathological complete response in triple negative breast cancer"

Corrigendum: Neoadjuvant Tislelizumab Combined with Chemotherapy in Locally Advanced Oral or Oropharyngeal Squamous Cell Carcinoma: a Real-World Retrospective Study.

Erratum: Preoperative Frailty Risk in Cranioplasty Patients: Risk Analysis Index Predicts Adverse Outcomes-Erratum

ERRATUM: Correction of the Conflict of Interest. Difference in prognostic impact of lateral pelvic lymph node metastasis between pre- and post-neoadjuvant chemoradiotherapy in rectal cancer patients

The autophagy-related genes Beclin1 and LC3 in the prognosis of pancreatic cancer [Retraction]

Erratum: Mesenchymal Stem Cell-Based NK4 Gene Therapy in Nude Mice Bearing Gastric Cancer Xenografts [Corrigendum]